-
1Academic Journal
Authors: A. V. Polynovsky, D. V. Kuzmichev, A. A. Tryakin, M. V. Chernykh, O. A. Kuznetsova, I. A. Karasev, D. V. Aleksantsev, A. M. Karachun, E. V. Tkachenko, E. I. Turyaeva, D. V. Samsonov, I. M. Gridasov, S. E. Prokofiev, Z. Z. Mamedli, А. В. Полыновский, Д. В. Кузьмичев, А. А. Трякин, М. В. Черных, О. А. Кузнецова, И. А. Карасев, Д. В. Алексанцев, А. М. Карачун, Е. В. Ткаченко, Е. И. Тюряева, Д. В. Самсонов, И. М. Гридасов, С. Е. Прокофьев, З. З. Мамедли
Source: Surgery and Oncology; Том 15, № 1 (2025); 18-27 ; Хирургия и онкология; Том 15, № 1 (2025); 18-27 ; 2949-5857
Subject Terms: индукционная/консолидирующая химиотерапия, total neoadjuvant chemotherapy, chemoradiotherapy, induction/consolidation chemotherapy, тотальная неоадъювантная химиотерапия, химиолучевая терапия
File Description: application/pdf
Relation: https://www.onco-surgery.info/jour/article/view/777/490; Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019. 250 с.; Breugom A.J., van den Broek C.B.M., van Gijn W. et al. The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemotherapy followed by TMEsurgery: the PROCTOR/SCRIPT study. Eur J Cancer 2013;49:1.; Cionini L., Sainato A., de Paoli A. et al. Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer. Radiother Oncol 2010;96:113–4.; Glynne-Jones R., Chau I. Neoadjuvant therapy before surgical treatment. EJC Suppl 2013;11(2):45–59.; Rödel C., Liersch T., Becker H. et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/ AIO-04 randomised phase 3 trial. Lancet Oncol 2012;13:679–87.; Ludmir E.B., Palta M., Willett C.G. et al. Total neoadjuvant therapy for rectal cancer: an emerging option. Cancer 2017;123:1497–506. DOI:10.1002/cncr.30600; Franke A.J., Parekh H., Starr J.S. et al. Total neoadjuvant therapy: a shifting paradigm in locally advanced rectal cancer management. Clin Colorectal Cancer 2018;17:1–12.; Bahadoer R.R., Dijkstra E.A., van Etten B. et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol 2020;22(1):29–42. DOI:10.1016/S1470-2045(20)30555-6; Conroy T., Bosset J.-F., Etienne P-L. et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, openlabel, phase 3 trial. Lancet Oncol 2021;22(5):702–15. DOI:10.1016/S1470-2045(21)00079-6; Jin J., Tang Y., Hu C. et al. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol 2022;40(15):1681–92. DOI:10.1200/JCO.21.01667; Liao C.-K., Kuo Y.-T., Lin Y.-C. et. al. Neoadjuvant short-course radiotherapy followed by consolidation chemotherapy before surgery for treating locally advanced rectal cancer: a systematic review and meta-analysis. Curr Oncol 2022;29(5):3708–27. DOI:10.3390/curroncol29050297; Gabbani M., Giorgi C., Napoli G. et al. Outcomes of locally advanced rectal cancer patients treated with total neoadjuvant treatment: a meta-anaysis of randomized controlled trials. Clin Colorectal Cancer 2022;21(4):297–308. DOI:10.1016/j.clcc.2022.07.005; Petrelli F., Trevisan F., Cabiddu M. et al. Total neoadjuvant therapy in rectal cancer: a systematic review and meta-analysis of treatment outcomes. Ann Surg 2020;271(3):440–8. DOI:10.1097/SLA.0000000000003471; Liu S., Jiang T., Xiao L. et al. Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis. Oncologist 2021;26(9):e1555–e6. DOI:10.1002/onco.13824; Maas M., Nelemans P.J., Valentini V. et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010;11:835–44.; Habr-Gama A., Perez R.O., Nadalin W. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004;240(4):711–7. DOI:10.1097/01.sla.0000141194.27992.32; Romesser P.B., Park B.K., Nemirovsky D. et al. Organ preservation and total neoadjuvant therapy for rectal cancer: investigating long course chemoradiation versus short-course radiation therapy. J Clin Oncol 2023;41(4):10. DOI:10.1200/JCO.2023.41.4_suppl.10; Cionini L., Sainato A., de Paoli A. et al. Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer. Radiother Oncol 2010;96:S113–4.
-
2Academic Journal
Source: Malignant tumours; Том 12, № 3s1 (2022); 69-75 ; Злокачественные опухоли; Том 12, № 3s1 (2022); 69-75 ; 2587-6813 ; 2224-5057
Subject Terms: индукционная / консолидирующая химиотерапия, тотальная неоадъювантная химиотерапия, химиолучевая терапия
File Description: application/pdf
Relation: https://www.malignanttumors.org/jour/article/view/1003/700; Kaprin A. D. Malignant neoplasms in Russia in 2018 (morbidity and mortality) // P. Hertsen Moscow Oncology Research Institute, 2019–249 p.; Breugom AJ, van den Broek CBM, van Gijn W, et al. The value of adjuvant chemotherapy in rectal cancer patients after preoperative radiotherapy or chemotherapy followed by TME-surgery : the PROCTOR / SCRIPT study // Eur J Cancer. 2013. 49, S1.; Cionini L, Sainato A, De Paoli A et al. Final results of randomized trial on adjuvant chemotherapy after preoperative chemoradiation in rectal cancer. // Radiother Oncol. 2010. 96, S113-S114.; Glynne-Jones R, Chau I. Neoadjuvant therapy before surgical treatment. // EJC Suppl. 2013 EJC Suppl. 2013. 11 (2), 45–59.; Rödel C, Liersch T, Becker H, et al. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer : initial results of the German CAO / ARO / AIO-04 randomised phase 3 trial. Lancet Oncol. 2012; 13 : 679–687.].; Ludmir EB, Palta M, Willett CG, et al. Total neoadjuvant therapy for rectal cancer : An emerging option. Cancer. 2017; 123 : 1497–1506. doi:10.1002/cncr.30600.; Franke AJ, Parekh H, Starr JS, et al. Total neoadjuvant therapy : a shifting paradigm in locally advanced rectal cancer management. Clin Colorectal Cancer. 2018; 17 : 1–12.; Gabbani M., Giorgi C., Napoli G. et al. Outcomes of Locally Advanced Rectal Cancer Patients Treated with Total Neoadjuvant Treatment : A Meta-Anaysis of Randomized Controlled Trials. Clinical Colorectal Cancer, Vol. 000, No. xxx, 1–12 ©2022.; Fernández-Martos C., Pericay C., Aparicio J., et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defi ned, locally advanced rectal cancer : Grupo cancer de recto 3 study. J Clin Oncol. 2010; 28 (5) : 859–65.; Fokas E., Phil D., Allgauer M. et al. Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer : CAO / ARO / AIO-12. Journal of Clinical Oncology 2019; 37. DOI https://doi.org/10.1200/JCO.19.00308.; Gao Y. H., Lin J. Z., An X. et al. Neoadjuvant Sandwich Treatment with Oxaliplatin and Capecitabine Administered Prior to, Concurrently with, and Following Radiation Therapy in Locally Advanced Rectal Cancer : a Prospective Phase 2 Trial // Int. J. Radiat. Oncol. Biol. Phys. 2014. V. 90, No. 5. P. 1153–1160.; Marco MR, Zhou L, Patil S, et al : Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer : Final results of a multicenter phase II trial. Dis Colon Rectum 61 : 1146–1155, 2018.; Maas M, Nelemans PJ, Valentini V, et al : Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer : A pooled analysis of individual patient data. Lancet Oncol 11 : 835–844, 2010.; https://www.malignanttumors.org/jour/article/view/1003